Oxford Biomedica plc (OTCMKTS:OXBDF - Get Free Report) was the target of a large growth in short interest in the month of February. As of February 28th, there was short interest totalling 78,300 shares, a growth of 131.0% from the February 13th total of 33,900 shares. Currently, 0.1% of the company's shares are sold short. Based on an average daily volume of 4,600 shares, the days-to-cover ratio is currently 17.0 days.
Oxford Biomedica Stock Performance
Shares of OTCMKTS:OXBDF opened at $3.53 on Friday. The company has a current ratio of 2.35, a quick ratio of 2.07 and a debt-to-equity ratio of 1.48. Oxford Biomedica has a 1 year low of $2.40 and a 1 year high of $5.68. The stock has a 50-day simple moving average of $4.83 and a 200-day simple moving average of $4.97.
About Oxford Biomedica
(
Get Free Report)
Oxford Biomedica plc, a contract development and manufacturing organization, focuses on delivering therapies to patients worldwide. Its s LentiVector platform technology is an advanced lentiviral vector based gene delivery system which is designed to overcome the safety and delivery problems associated with earlier generations of vector systems.
See Also
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Oxford Biomedica, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Oxford Biomedica wasn't on the list.
While Oxford Biomedica currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering what the next stocks will be that hit it big, with solid fundamentals? Enter your email address to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
